tradingkey.logo

Collegium Pharmaceutical Inc

COLL

31.140USD

+1.070+3.56%
交易中 美東報價延遲15分鐘
1.00B總市值
22.80本益比TTM

Collegium Pharmaceutical Inc

31.140

+1.070+3.56%
關於 Collegium Pharmaceutical Inc 公司
Collegium Pharmaceutical, Inc. 是一家多元化的專業製藥公司。該公司在美國銷售其止痛藥產品組合,包括 Xtampza 緩釋 (ER)、Nucynta ER 和 Nucynta 速釋 (IR)、Belbuca 和 Symproic。Xtampza ER 是一種抗濫用緩釋口服羥可酮製劑。Xtampza ER 是一種具有抗濫用特性的止痛藥治療方案,使用技術平臺 DETERx。Nucynta 產品是他噴他多的 ER 和 IR 口服制劑。Nucynta ER 用於治療需要長期每日服用阿片類止痛藥治療的嚴重和持續性疼痛。Nucynta IR 用於治療嚴重到需要服用阿片類止痛藥的急性疼痛。Belbuca 是一種含丁丙諾啡的頰膜,用於治療嚴重和持續性疼痛。 Symproic 用於治療成人患者阿片類藥物引起的便祕 (OIC)。其產品組合還包括 Jornay PM。
公司簡介
公司代碼COLL
公司名稱Collegium Pharmaceutical Inc
上市日期May 07, 2015
CEOMr. Vikram Karnani
員工數量357
證券類型Ordinary Share
年結日May 07
公司地址100 Technology Center Dr
城市STOUGHTON
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編02072-4710
電話17817133699
網址https://www.collegiumpharma.com/
公司代碼COLL
上市日期May 07, 2015
CEOMr. Vikram Karnani
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Vikram Karnani
Mr. Vikram Karnani
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
105.97K
--
Mr. David Dieter
Mr. David Dieter
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
68.45K
--
Ms. Colleen Tupper
Ms. Colleen Tupper
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
42.18K
-37.97%
Mr. Gino Santini
Mr. Gino Santini
Independent Chairman of the Board
Independent Chairman of the Board
35.23K
+38.49%
Dr. Rita J. Balice-Gordon, Ph.D.
Dr. Rita J. Balice-Gordon, Ph.D.
Independent Director
Independent Director
33.77K
+40.84%
Ms. Nancy S. Lurker
Ms. Nancy S. Lurker
Independent Director
Independent Director
22.52K
+76.94%
Dr. Carlos V. Paya, M.D., Ph.D.
Dr. Carlos V. Paya, M.D., Ph.D.
Independent Director
Independent Director
19.58K
--
Mr. Garen G. Bohlin
Mr. Garen G. Bohlin
Independent Director
Independent Director
--
--
Dr. John A. Fallon, M.D.
Dr. John A. Fallon, M.D.
Independent Director
Independent Director
--
--
Ms. Jane Gonnerman
Ms. Jane Gonnerman
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Vikram Karnani
Mr. Vikram Karnani
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
105.97K
--
Mr. David Dieter
Mr. David Dieter
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
68.45K
--
Ms. Colleen Tupper
Ms. Colleen Tupper
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
42.18K
-37.97%
Mr. Gino Santini
Mr. Gino Santini
Independent Chairman of the Board
Independent Chairman of the Board
35.23K
+38.49%
Dr. Rita J. Balice-Gordon, Ph.D.
Dr. Rita J. Balice-Gordon, Ph.D.
Independent Director
Independent Director
33.77K
+40.84%
Ms. Nancy S. Lurker
Ms. Nancy S. Lurker
Independent Director
Independent Director
22.52K
+76.94%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Nucynta IR
75.06M
42.23%
Xtampza ER
51.66M
29.06%
Jomay PM
28.54M
16.06%
Belbuca
27.42M
15.42%
Nucynta ER
19.69M
11.07%
Symproic
2.81M
1.58%
暫無數據
業務
地區
業務USD
名稱
營收
佔比
Nucynta IR
75.06M
42.23%
Xtampza ER
51.66M
29.06%
Jomay PM
28.54M
16.06%
Belbuca
27.42M
15.42%
Nucynta ER
19.69M
11.07%
Symproic
2.81M
1.58%
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
15.05%
Rubric Capital Management LP
9.33%
Eventide Asset Management, LLC
8.21%
The Vanguard Group, Inc.
6.97%
Renaissance Technologies LLC
5.03%
Other
55.41%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
15.05%
Rubric Capital Management LP
9.33%
Eventide Asset Management, LLC
8.21%
The Vanguard Group, Inc.
6.97%
Renaissance Technologies LLC
5.03%
Other
55.41%
股東類型
持股股東
佔比
Investment Advisor
59.13%
Investment Advisor/Hedge Fund
31.78%
Hedge Fund
20.75%
Research Firm
3.18%
Individual Investor
1.79%
Pension Fund
1.21%
Bank and Trust
0.45%
Sovereign Wealth Fund
0.41%
Venture Capital
0.07%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
511
38.19M
118.82%
-4.98M
2025Q1
528
38.32M
119.23%
-5.70M
2024Q4
520
38.61M
122.59%
-6.60M
2024Q3
498
39.90M
123.83%
-6.67M
2024Q2
486
41.00M
125.33%
-4.08M
2024Q1
464
41.14M
125.78%
-3.32M
2023Q4
434
40.31M
123.54%
-3.32M
2023Q3
425
39.87M
114.82%
-4.18M
2023Q2
428
40.45M
116.96%
-4.39M
2023Q1
425
40.62M
117.50%
-1.29M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
4.84M
15.05%
-111.68K
-2.26%
Mar 31, 2025
Rubric Capital Management LP
3.00M
9.33%
+650.00K
+27.66%
Mar 31, 2025
Eventide Asset Management, LLC
2.64M
8.21%
+845.00
+0.03%
Mar 31, 2025
The Vanguard Group, Inc.
2.24M
6.97%
-36.10K
-1.59%
Mar 31, 2025
Renaissance Technologies LLC
1.62M
5.03%
-45.50K
-2.74%
Mar 31, 2025
Principal Global Investors (Equity)
1.57M
4.89%
-71.69K
-4.36%
Mar 31, 2025
Emerald Advisers LLC
1.40M
4.36%
+19.31K
+1.40%
Mar 31, 2025
State Street Global Advisors (US)
1.38M
4.28%
-62.15K
-4.32%
Mar 31, 2025
Fuller & Thaler Asset Management Inc.
1.37M
4.27%
+19.57K
+1.45%
Mar 31, 2025
Invesco Advisers, Inc.
953.91K
2.97%
-27.98K
-2.85%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco Pharmaceuticals ETF
2.71%
Invesco Biotechnology & Genome ETF
2.67%
SPDR S&P Pharmaceuticals ETF
1.53%
Ballast Small/Mid Cap ETF
1.34%
ETC 6 Meridian Small Cap Equity ETF
1.16%
Invesco S&P SmallCap 600 GARP ETF
1.13%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.09%
VictoryShares Small Cap Free Cash Flow ETF
0.83%
Invesco S&P SmallCap 600 Pure Growth ETF
0.71%
Invesco S&P SmallCap Health Care ETF
0.68%
查看更多
Invesco Pharmaceuticals ETF
佔比2.71%
Invesco Biotechnology & Genome ETF
佔比2.67%
SPDR S&P Pharmaceuticals ETF
佔比1.53%
Ballast Small/Mid Cap ETF
佔比1.34%
ETC 6 Meridian Small Cap Equity ETF
佔比1.16%
Invesco S&P SmallCap 600 GARP ETF
佔比1.13%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比1.09%
VictoryShares Small Cap Free Cash Flow ETF
佔比0.83%
Invesco S&P SmallCap 600 Pure Growth ETF
佔比0.71%
Invesco S&P SmallCap Health Care ETF
佔比0.68%
分紅派息
近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
KeyAI